Hepatitis B: Clinical Trials

8 trials for Hepatitis B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 terminated. 8 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable8Terminated 8

Follow Hepatitis B: new trials by email Literature Review of Hepatitis B trials Research Report on Hepatitis B

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C
MagIA IBC test in capillary blood, MagIA IBC test in other blood matrices - Combined Point of Care Diagnostic of HIV, HBV and HCV
Not applicableTerminatedMagIA Diagnostics962024-09-162026-09-11
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation
Esophageal cooling/warming device, Mild hypothermia, Normothermia - Cirrhosis, End Stage Liver Disease
Not applicableTerminatedUniversity of California, San Francisco1752018-07-072025-05-16
Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients
Granulocyte Macrophage-colony Stimulating Factor, Entecavir - Hepatitis B, Chronic
Not applicableTerminatedBeijing 302 Hospital802017-01-012022-03-24
Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient
Blood sample - Chronic Renal Disease
Not applicableTerminatedCentre Hospitalier Universitaire de Besancon202014-03-012018-04-05
Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease
HBV DNA level monitoring - Inflammatory Bowel Disease, Crohn Disease
Not applicableTerminatedChinese University of Hong Kong4302013-02-012017-04-25
Response to Hepatitis B Vaccine in Celiac Disease Patients
hepatitis B vaccine (EngerixB) - Celiac Disease
Not applicableTerminatedShaare Zedek Medical Center2102009-02-012011-04-15
Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
Hepsera - Hepatitis B
Not applicableTerminatedGilead Sciences4002002-01-012007-03-08
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.
ACH-126, 443 (beta-L-Fd4C) - Chronic Hepatitis B
Not applicableTerminatedAlexion Pharmaceuticals, Inc.1002009-08-19

Narrower conditions

Hepatitis B, Chronic (4)  ·  Hepatitis C (2)  ·  Renal Insufficiency, Chronic (2)  ·  Acute Kidney Injury (1)  ·  Carcinoma, Hepatocellular (1)  ·  Celiac Disease (1)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  End Stage Liver Disease (1)  ·  Fibrosis (1)  ·  Hypothermia (1)  ·  Inflammatory Bowel Diseases (1)  ·  Liver Cirrhosis, Alcoholic (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Blood-Borne Infections (8)  ·  Communicable Diseases (8)  ·  DNA Virus Infections (8)  ·  Digestive System Diseases (8)  ·  Hepadnaviridae Infections (8)  ·  Hepatitis (8)  ·  Hepatitis, Viral, Human (8)  ·  Infections (8)  ·  Liver Diseases (8)  ·  Virus Diseases (8)  ·  Chronic Disease (6)  ·  Disease Attributes (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Hepatitis, Chronic (4)

Interventions

Blood Specimen Collection (1)  ·  Colony-Stimulating Factors (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Hepatitis B Vaccines (1)  ·  Hypothermia, Induced (1)  ·  adefovir dipivoxil (1)  ·  dexelvucitabine (1)  ·  entecavir (1)  ·  halofantrine (1)

Sponsors

Alexion Pharmaceuticals, Inc. (1)  ·  Beijing 302 Hospital (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Chinese University of Hong Kong (1)  ·  Gilead Sciences (1)  ·  MagIA Diagnostics (1)  ·  Shaare Zedek Medical Center (1)  ·  University of California, San Francisco (1)

Countries

France (2)  ·  China (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Ari Silbermintz (1)  ·  Maskit Bar Meir, MD (1)  ·  Michael P Bokoch, MD, PhD (1)  ·  Ping Zhao, Director (1)  ·  Siew Chien Ng (1)